Published by Benjamin Chiou on 13th February 2026
(Sharecast News) - Moderna revenues fell by almost a third over the final quarter of 2025, though the American pharma giant reported a narrower loss than expected, causing shares to rise in pre-market trading.
URL: http://www.digitallook.com/dl/news/story/35699294/...